1
CARIS LIFE SCIENCES INC
COM
CAI
CAI
8,256,032
$147.1m5.44%
5.44%
Added Shares held: Q3 2025 7.3m, Q4 2025 7.8m, Q1 2026 8.0m, Q2 2026 8.3m
+246.6k
+246,585
3.1%
2
HINGE HEALTH INC
CL A
HNGE
HNGE
1,330,127
$110.4m4.08%
4.08%
Reduced Shares held: Q3 2025 910.5k, Q4 2025 1.3m, Q1 2026 1.5m, Q2 2026 1.3m
-125.0k
-124,996
-8.6%
3
GLAUKOS CORP
COM
GKOS
GKOS
591,927
$82.7m3.06%
3.06%
Reduced Shares held: Q3 2025 780.2k, Q4 2025 922.0k, Q1 2026 763.5k, Q2 2026 591.9k
-171.6k
-171,578
-22.5%
4
EDGEWISE THERAPEUTICS INC
COM
EWTX
EWTX
1,996,965
$81.1m3.00%
3.00%
Reduced Shares held: Q3 2025 5.2m, Q4 2025 5.2m, Q1 2026 2.3m, Q2 2026 2.0m
-350.6k
-350,618
-14.9%
5
SPYRE THERAPEUTICS INC
COM NEW
SYRE
SYRE
879,467
$78.1m2.89%
2.89%
Reduced Shares held: Q3 2025 2.6m, Q4 2025 1.6m, Q1 2026 932.8k, Q2 2026 879.5k
-53.4k
-53,356
-5.7%
6
IRHYTHM TECHNOLOGIES INC
COM
IRTC
IRTC
654,262
$77.8m2.88%
2.88%
Added Shares held: Q3 2025 225.8k, Q4 2025 217.3k, Q1 2026 610.2k, Q2 2026 654.3k
+44.1k
+44,070
7.2%
7
NEOGENOMICS INC
COM NEW
NEO
NEO
4,918,202
$71.8m2.65%
2.65%
Reduced Shares held: Q3 2025 1.8m, Q4 2025 4.6m, Q1 2026 5.6m, Q2 2026 4.9m
-699.2k
-699,200
-12.4%
8
KODIAK SCIENCES INC
COM
KOD
KOD
1,787,318
$69.6m2.58%
2.58%
Reduced Shares held: Q3 2025 0, Q4 2025 2.1m, Q1 2026 1.8m, Q2 2026 1.8m
-31.3k
-31,347
-1.7%
9
XENON PHARMACEUTICALS INC
COM
XENE
XENE
1,131,452
$68.3m2.53%
2.53%
Reduced Shares held: Q3 2025 3.6m, Q4 2025 1.8m, Q1 2026 1.3m, Q2 2026 1.1m
-207.0k
-207,000
-15.5%
10
ALPHATEC HLDGS INC
NOTE 0.750% 3/1 · principal
ATEC 0.75 03.15.30 · principal
ATEC 0.75 03.15.30
69,121,000
$66.2m2.45%
2.45%
Added Principal held: Q3 2025 0, Q4 2025 0, Q1 2026 61.6m, Q2 2026 69.1m
+7.5m
+7,500,000
12.2%
11
MONTE ROSA THERAPEUTICS INC
COM
GLUE
GLUE
2,451,562
$59.3m2.19%
2.19%
Reduced Shares held: Q3 2025 0, Q4 2025 948.3k, Q1 2026 3.2m, Q2 2026 2.5m
-755.0k
-755,012
-23.6%
12
DIANTHUS THERAPEUTICS INC
COM
DNTH
DNTH
594,562
$58.0m2.14%
2.14%
Reduced Shares held: Q3 2025 835.1k, Q4 2025 1.3m, Q1 2026 899.4k, Q2 2026 594.6k
-304.8k
-304,802
-33.9%
13
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
336,171
$56.7m2.10%
2.10%
Reduced Shares held: Q3 2025 880.3k, Q4 2025 751.5k, Q1 2026 652.1k, Q2 2026 336.2k
-315.9k
-315,950
-48.5%
14
ALPHATEC HLDGS INC
COM NEW
ATEC
ATEC
6,531,439
$56.5m2.09%
2.09%
Added Shares held: Q3 2025 1.5m, Q4 2025 0, Q1 2026 2.2m, Q2 2026 6.5m
+4.4m
+4,358,714
200.6%
15
GENERATE BIOMEDICINES INC
COM SHS
GENB
GENB
3,283,844
$55.4m2.05%
2.05%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 3.6m, Q2 2026 3.3m
-309.2k
-309,155
-8.6%
16
MARAVAI LIFESCIENCES HLDGS I
COM CL A
MRVI
MRVI
8,702,921
$54.3m2.01%
2.01%
Reduced Shares held: Q3 2025 8.4m, Q4 2025 8.4m, Q1 2026 10.2m, Q2 2026 8.7m
-1.5m
-1,537,243
-15.0%
17
KRYSTAL BIOTECH INC
COM
KRYS
KRYS
128,975
$47.9m1.77%
1.77%
Reduced Shares held: Q3 2025 520.4k, Q4 2025 202.1k, Q1 2026 182.4k, Q2 2026 129.0k
-53.5k
-53,450
-29.3%
18
HUMANA INC
COM
HUM
HUM
114,500
$45.5m1.68%
1.68%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 114.5k
19
THERMO FISHER SCIENTIFIC INC
COM
TMO
TMO
89,395
$44.8m1.66%
1.66%
Reduced Shares held: Q3 2025 113.9k, Q4 2025 80.7k, Q1 2026 92.9k, Q2 2026 89.4k
-3.5k
-3,520
-3.8%
20
KYMERA THERAPEUTICS INC
COM
KYMR
KYMR
378,163
$43.4m1.60%
1.60%
Added Shares held: Q3 2025 276.7k, Q4 2025 454.3k, Q1 2026 337.6k, Q2 2026 378.2k
+40.6k
+40,604
12.0%
21
RHYTHM PHARMACEUTICALS INC
COM
RYTM
RYTM
381,128
$42.3m1.57%
1.57%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 310.6k, Q2 2026 381.1k
+70.5k
+70,500
22.7%
22
DAMORA THERAPEUTICS INC
COM NEW
COM NEW
1,620,377
$42.1m1.56%
1.56%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 894.8k, Q2 2026 1.6m
+725.5k
+725,531
81.1%
23
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
1,646,399
$41.7m1.54%
1.54%
Reduced Shares held: Q3 2025 2.4m, Q4 2025 2.0m, Q1 2026 2.5m, Q2 2026 1.6m
-824.8k
-824,800
-33.4%
24
BRIGHTSPRING HEALTH SVCS INC
COM
BTSG
BTSG
596,753
$41.6m1.54%
1.54%
Reduced Shares held: Q3 2025 0, Q4 2025 1.2m, Q1 2026 1.0m, Q2 2026 596.8k
-419.8k
-419,809
-41.3%
25
TRANSMEDICS GROUP INC
COM
TMDX
TMDX
609,715
$40.5m1.50%
1.50%
Added Shares held: Q3 2025 351.2k, Q4 2025 315.3k, Q1 2026 329.4k, Q2 2026 609.7k
+280.3k
+280,324
85.1%
26
MBX BIOSCIENCES INC
COM
MBX
MBX
710,880
$39.2m1.45%
1.45%
Reduced Shares held: Q3 2025 0, Q4 2025 1.0m, Q1 2026 1.5m, Q2 2026 710.9k
-781.6k
-781,587
-52.4%
27
CLIMB BIO INC
COM
CLYM
CLYM
2,797,375
$36.5m1.35%
1.35%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.5m, Q2 2026 2.8m
+1.3m
+1,267,700
82.9%
28
CAREDX INC
COM
CDNA
CDNA
1,220,602
$34.8m1.29%
1.29%
Reduced Shares held: Q3 2025 2.2m, Q4 2025 1.6m, Q1 2026 2.2m, Q2 2026 1.2m
-952.5k
-952,544
-43.8%
29
MAZE THERAPEUTICS INC
COM
MAZE
MAZE
1,140,040
$34.0m1.26%
1.26%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
30
BRIGHT MINDS BIOSCIENCES INC
COM NEW
DRUG
DRUG
483,822
$34.0m1.26%
1.26%
Reduced Shares held: Q3 2025 303.7k, Q4 2025 324.4k, Q1 2026 539.7k, Q2 2026 483.8k
-55.9k
-55,886
-10.3%
31
ACADIA HEALTHCARE COMPANY IN
COM
ACHC
ACHC
1,141,477
$33.7m1.25%
1.25%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 645.9k, Q2 2026 1.1m
+495.6k
+495,577
76.7%
32
NEKTAR THERAPEUTICS
COM NEW
NKTR
NKTR
473,617
$33.1m1.22%
1.22%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 222.7k, Q2 2026 473.6k
+250.9k
+250,916
112.7%
33
CORVUS PHARMACEUTICALS INC
COM
CRVS
CRVS
2,126,298
$31.8m1.18%
1.18%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.8m, Q2 2026 2.1m
+373.5k
+373,500
21.3%
34
NURIX THERAPEUTICS INC
COM
NRIX
NRIX
1,286,769
$31.2m1.15%
1.15%
Reduced Shares held: Q3 2025 0, Q4 2025 2.2m, Q1 2026 1.8m, Q2 2026 1.3m
-464.0k
-463,997
-26.5%
35
INSPIRE MED SYS INC
COM
INSP
INSP
677,570
$30.2m1.12%
1.12%
Unchanged Shares held: Q3 2025 883.7k, Q4 2025 540.9k, Q1 2026 677.6k, Q2 2026 677.6k
36
AVALO THERAPEUTICS INC
COM NEW
AVTX
AVTX
1,629,182
$30.1m1.11%
1.11%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.6m
37
ALAMAR BIOSCIENCES INC
COMMON STOCK
ALMR
ALMR
1,083,983
$29.4m1.09%
1.09%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
38
DANAHER CORPORATION
COM
DHR
DHR
150,627
$28.7m1.06%
1.06%
Added Shares held: Q3 2025 309.3k, Q4 2025 118.2k, Q1 2026 139.3k, Q2 2026 150.6k
+11.3k
+11,300
8.1%
39
INTUITIVE SURGICAL INC
COM NEW
ISRG
ISRG
70,137
$27.9m1.03%
1.03%
Reduced Shares held: Q3 2025 130.2k, Q4 2025 83.4k, Q1 2026 77.3k, Q2 2026 70.1k
-7.2k
-7,160
-9.3%
40
ORUKA THERAPEUTICS INC
COM
ORKA
ORKA
278,164
$26.5m0.98%
0.98%
New Shares held: Q3 2025 1.4m, Q4 2025 84.8k, Q1 2026 0, Q2 2026 278.2k
41
AVALYN PHARMACEUTICALS INC
COM SHS
AVLN
AVLN
801,395
$26.4m0.98%
0.98%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 801.4k
42
AVEANNA HEALTHCARE HLDGS INC
COM
AVAH
AVAH
3,065,106
$26.3m0.97%
0.97%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.2m, Q2 2026 3.1m
+861.6k
+861,600
39.1%
43
BIOAGE LABS INC
COM
BIOA
BIOA
1,033,129
$25.3m0.94%
0.94%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 1.0m
-167.5k
-167,458
-13.9%
44
BOSTON SCIENTIFIC CORP
COM
BSX
BSX
587,567
$25.1m0.93%
0.93%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 346.5k, Q2 2026 587.6k
+241.1k
+241,100
69.6%
45
VERA THERAPEUTICS INC
CL A
VERA
VERA
564,724
$24.2m0.90%
0.90%
Added Shares held: Q3 2025 472.7k, Q4 2025 784.7k, Q1 2026 523.8k, Q2 2026 564.7k
+40.9k
+40,900
7.8%
46
REPLIGEN CORP
COM
RGEN
RGEN
177,100
$24.2m0.89%
0.89%
Added Shares held: Q3 2025 195.7k, Q4 2025 81.8k, Q1 2026 47.5k, Q2 2026 177.1k
+129.6k
+129,600
272.8%
47
ZURA BIO LTD
CLASS A ORD SHS
ZURA
ZURA
3,980,295
$23.5m0.87%
0.87%
Reduced Shares held: Q3 2025 2.5m, Q4 2025 3.2m, Q1 2026 4.0m, Q2 2026 4.0m
-8.7k
-8,694
-0.2%
48
GUARDANT HEALTH INC
COM
GH
GH
147,850
$22.2m0.82%
0.82%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 499.7k, Q2 2026 147.8k
-351.9k
-351,862
-70.4%
49
EVOLUS INC
COM
EOLS
EOLS
3,155,209
$21.9m0.81%
0.81%
Added Shares held: Q3 2025 0, Q4 2025 3.1m, Q1 2026 3.1m, Q2 2026 3.2m
+50.0k
+50,000
1.6%
50
NATERA INC
COM
NTRA
NTRA
79,500
$21.6m0.80%
0.80%
Reduced Shares held: Q3 2025 0, Q4 2025 111.5k, Q1 2026 129.0k, Q2 2026 79.5k
-49.5k
-49,500
-38.4%
51
ORTHOPEDIATRICS CORP
COM
KIDS
KIDS
1,100,370
$21.1m0.78%
0.78%
Unchanged Shares held: Q3 2025 1.1m, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.1m
52
ELEVANCE HEALTH INC
COM
ELV
ELV
53,960
$20.9m0.77%
0.77%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 62.1k, Q2 2026 54.0k
-8.1k
-8,120
-13.1%
53
TECTONIC THERAPEUTIC INC
COM
TECX
TECX
596,900
$20.5m0.76%
0.76%
Reduced Shares held: Q3 2025 736.9k, Q4 2025 927.5k, Q1 2026 847.2k, Q2 2026 596.9k
-250.3k
-250,251
-29.5%
54
DYNE THERAPEUTICS INC
COM
DYN
DYN
921,598
$20.5m0.76%
0.76%
Reduced Shares held: Q3 2025 2.7m, Q4 2025 1.5m, Q1 2026 1.7m, Q2 2026 921.6k
-760.4k
-760,400
-45.2%
55
NEOGENOMICS INC
NOTE 0.250% 1/1 · principal
NEO 0.25 01.15.28 · principal
NEO 0.25 01.15.28
18,011,000
$16.9m0.62%
0.62%
Reduced Principal held: Q3 2025 100.4m, Q4 2025 100.4m, Q1 2026 100.4m, Q2 2026 18.0m
-82.4m
-82,370,000
-82.1%
56
IMMUNOCORE HLDGS PLC
ADS
IMCR
IMCR
521,327
$16.6m0.61%
0.61%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 521.3k
57
REPLIGEN CORP
NOTE 1.000%12/1 · principal
RGEN 1 12.15.28 · principal
RGEN 1 12.15.28
16,000,000
$16.4m0.61%
0.61%
Reduced Principal held: Q3 2025 101.0m, Q4 2025 101.0m, Q1 2026 101.0m, Q2 2026 16.0m
-85.0m
-85,000,000
-84.2%
58
ARGENX SE
SPONSORED ADR
ARGX
ARGX
17,707
$16.4m0.61%
0.61%
Reduced Shares held: Q3 2025 76.1k, Q4 2025 31.0k, Q1 2026 84.9k, Q2 2026 17.7k
-67.2k
-67,232
-79.2%
59
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
436,646
$16.2m0.60%
0.60%
Reduced Shares held: Q3 2025 591.7k, Q4 2025 1.9m, Q1 2026 1.4m, Q2 2026 436.6k
-919.4k
-919,436
-67.8%
60
OVID THERAPEUTICS INC
COM
OVID
OVID
5,919,464
$15.9m0.59%
0.59%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.9m
61
MANNKIND CORP
COM NEW
MNKD
MNKD
3,458,429
$14.7m0.54%
0.54%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.5m
62
UNIQURE NV
SHS
QURE
QURE
301,652
$13.9m0.51%
0.51%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 301.7k
63
X4 PHARMACEUTICALS INC
COM NEW
XFOR
XFOR
2,922,754
$13.6m0.50%
0.50%
Reduced Shares held: Q3 2025 0, Q4 2025 3.4m, Q1 2026 3.3m, Q2 2026 2.9m
-350.2k
-350,200
-10.7%
64
ORIC PHARMACEUTICALS INC
COM
ORIC
ORIC
1,214,540
$13.2m0.49%
0.49%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 1.2m
+86.5k
+86,500
7.7%
65
KINIKSA PHARMACEUTICALS INTL
ORD SHS CL A
KNSA
KNSA
183,822
$11.8m0.43%
0.43%
Reduced Shares held: Q3 2025 643.2k, Q4 2025 313.8k, Q1 2026 272.5k, Q2 2026 183.8k
-88.7k
-88,700
-32.5%
66
OCULIS HOLDING AG
ORDINARY SHARES
OCS
OCS
834,183
$11.6m0.43%
0.43%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 834.2k
67
ACLARIS THERAPEUTICS INC
COM
ACRS
ACRS
2,142,348
$11.3m0.42%
0.42%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.7m, Q2 2026 2.1m
+443.2k
+443,232
26.1%
68
SEAPORT THERAPEUTICS INC
COMMON STOCK
SPTX
SPTX
500,000
$10.9m0.40%
0.40%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 500.0k
69
VOR BIOPHARMA INC
COM NEW
VOR
VOR
573,104
$10.6m0.39%
0.39%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 466.8k, Q2 2026 573.1k
+106.3k
+106,330
22.8%
70
SURROZEN INC
COM NEW
SRZN
SRZN
390,753
$10.1m0.38%
0.38%
Reduced Shares held: Q3 2025 140.0k, Q4 2025 470.0k, Q1 2026 396.1k, Q2 2026 390.8k
-5.3k
-5,347
-1.4%
71
IMMUNIC INC
COM NEW
IMUX
IMUX
645,010
$9.9m0.37%
0.37%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 645.0k
72
HELIX ACQUISITION CORP III
USD CL A ORD SHS
HLXC
HLXC
900,000
$9.5m0.35%
0.35%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 900.0k, Q2 2026 900.0k
73
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
116,762
$9.3m0.34%
0.34%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 130.9k, Q2 2026 116.8k
-14.1k
-14,100
-10.8%
74
QUEST DIAGNOSTICS INC
COM
DGX
DGX
43,200
$9.2m0.34%
0.34%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 43.2k
75
ADLAI NORTYE LTD
SPONSORED ADS
ANL
ANL
795,214
$9.1m0.34%
0.34%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 795.2k
76
TENAX THERAPEUTICS INC
COM NEW
TENX
TENX
584,412
$8.5m0.31%
0.31%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 584.4k
77
KARDIGAN INC
COM
KARD
KARD
300,000
$7.2m0.26%
0.26%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 300.0k
78
AMANAT ACQUISITION CORP
CL A ORD
AMAN
AMAN
700,000
$7.1m0.26%
0.26%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 700.0k
79
HEMAB THERAPEUTICS HLDGS INC
COM SHS
COAG
COAG
160,000
$5.9m0.22%
0.22%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 160.0k
80
GH RESEARCH PLC
ORDINARY SHARES
GHRS
GHRS
207,240
$5.6m0.21%
0.21%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 207.2k
81
WATERS CORP
COM
WAT
WAT
14,040
$5.3m0.19%
0.19%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 14.0k
82
RESEARCH ALLIANCE CORP III
ORD SHS CL A
RACC
RACC
400,000
$4.3m0.16%
0.16%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 400.0k
83
JATT II ACQUISITION CORP
ORD SHS
JATT
JATT
250,000
$2.8m0.11%
0.11%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
84
PULMONX CORP
COM
LUNG
LUNG
752,541
$978.3k0.04%
0.04%
Unchanged Shares held: Q3 2025 752.5k, Q4 2025 752.5k, Q1 2026 752.5k, Q2 2026 752.5k
85
VYNE THERAPEUTICS INC
COM
COM
916,077
$596.1k0.02%
0.02%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 916.1k, Q2 2026 916.1k
86
CYCLERION THERAPEUTICS INC
COM
COM
156,890
$531.9k0.02%
0.02%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 156.9k